Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 61

1.

Polyunsaturated fatty acid metabolism in prostate cancer.

Berquin IM, Edwards IJ, Kridel SJ, Chen YQ.

Cancer Metastasis Rev. 2011 Dec;30(3-4):295-309. doi: 10.1007/s10555-011-9299-7. Review.

2.

Omega-3 fatty acids induce apoptosis in human breast cancer cells and mouse mammary tissue through syndecan-1 inhibition of the MEK-Erk pathway.

Sun H, Hu Y, Gu Z, Owens RT, Chen YQ, Edwards IJ.

Carcinogenesis. 2011 Oct;32(10):1518-24. doi: 10.1093/carcin/bgr132. Epub 2011 Jul 18.

3.

A high ratio of dietary n-6/n-3 polyunsaturated fatty acids is associated with increased risk of prostate cancer.

Williams CD, Whitley BM, Hoyo C, Grant DJ, Iraggi JD, Newman KA, Gerber L, Taylor LA, McKeever MG, Freedland SJ.

Nutr Res. 2011 Jan;31(1):1-8. doi: 10.1016/j.nutres.2011.01.002.

PMID:
21310299
4.

Syndecan-1-dependent suppression of PDK1/Akt/bad signaling by docosahexaenoic acid induces apoptosis in prostate cancer.

Hu Y, Sun H, Owens RT, Gu Z, Wu J, Chen YQ, O'Flaherty JT, Edwards IJ.

Neoplasia. 2010 Oct;12(10):826-36.

5.

Poxytrins, a class of oxygenated products from polyunsaturated fatty acids, potently inhibit blood platelet aggregation.

Chen P, Véricel E, Lagarde M, Guichardant M.

FASEB J. 2011 Jan;25(1):382-8. doi: 10.1096/fj.10-161836. Epub 2010 Sep 10.

PMID:
20833872
6.

Transgenic expression of 15-lipoxygenase 2 (15-LOX2) in mouse prostate leads to hyperplasia and cell senescence.

Suraneni MV, Schneider-Broussard R, Moore JR, Davis TC, Maldonado CJ, Li H, Newman RA, Kusewitt D, Hu J, Yang P, Tang DG.

Oncogene. 2010 Jul 29;29(30):4261-75. doi: 10.1038/onc.2010.197. Epub 2010 May 31.

7.

Docosahexaenoic acid metabolome in neural tumors: identification of cytotoxic intermediates.

Gleissman H, Yang R, Martinod K, Lindskog M, Serhan CN, Johnsen JI, Kogner P.

FASEB J. 2010 Mar;24(3):906-15. doi: 10.1096/fj.09-137919. Epub 2009 Nov 4.

8.

Decorin suppresses prostate tumor growth through inhibition of epidermal growth factor and androgen receptor pathways.

Hu Y, Sun H, Owens RT, Wu J, Chen YQ, Berquin IM, Perry D, O'Flaherty JT, Edwards IJ.

Neoplasia. 2009 Oct;11(10):1042-53.

9.
10.

Prostate tumor growth can be modulated by dietarily targeting the 15-lipoxygenase-1 and cyclooxygenase-2 enzymes.

Kelavkar UP, Hutzley J, McHugh K, Allen KG, Parwani A.

Neoplasia. 2009 Jul;11(7):692-9.

11.

Selective survival rescue in 15-lipoxygenase-1-deficient retinal pigment epithelial cells by the novel docosahexaenoic acid-derived mediator, neuroprotectin D1.

Calandria JM, Marcheselli VL, Mukherjee PK, Uddin J, Winkler JW, Petasis NA, Bazan NG.

J Biol Chem. 2009 Jun 26;284(26):17877-82. doi: 10.1074/jbc.M109.003988. Epub 2009 Apr 29.

12.

Biogenic synthesis, purification, and chemical characterization of anti-inflammatory resolvins derived from docosapentaenoic acid (DPAn-6).

Dangi B, Obeng M, Nauroth JM, Teymourlouei M, Needham M, Raman K, Arterburn LM.

J Biol Chem. 2009 May 29;284(22):14744-59. doi: 10.1074/jbc.M809014200. Epub 2009 Mar 26.

13.

Inhibition of arachidonic acid metabolism and its implication on cell proliferation and tumour-angiogenesis.

Hyde CA, Missailidis S.

Int Immunopharmacol. 2009 Jun;9(6):701-15. doi: 10.1016/j.intimp.2009.02.003. Epub 2009 Feb 23. Review.

PMID:
19239926
14.

Dietary habits and prostate cancer detection: a case-control study.

Amin M, Jeyaganth S, Fahmy N, Bégin LR, Aronson S, Jacobson S, Tanguay S, Kassouf W, Aprikian A.

Can Urol Assoc J. 2008 Oct;2(5):510-5.

15.

Substrate specificity changes for human reticulocyte and epithelial 15-lipoxygenases reveal allosteric product regulation.

Wecksler AT, Kenyon V, Deschamps JD, Holman TR.

Biochemistry. 2008 Jul 15;47(28):7364-75. doi: 10.1021/bi800550n. Epub 2008 Jun 21.

16.

In vivo and in vitro regulation of syndecan 1 in prostate cells by n-3 polyunsaturated fatty acids.

Edwards IJ, Sun H, Hu Y, Berquin IM, O'Flaherty JT, Cline JM, Rudel LL, Chen YQ.

J Biol Chem. 2008 Jun 27;283(26):18441-9. doi: 10.1074/jbc.M802107200. Epub 2008 Apr 30.

17.

Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators.

Serhan CN, Chiang N, Van Dyke TE.

Nat Rev Immunol. 2008 May;8(5):349-61. doi: 10.1038/nri2294. Review.

18.

Identification of inflammatory and proresolving lipid mediators in bone marrow and their lipidomic profiles with ovariectomy and omega-3 intake.

Poulsen RC, Gotlinger KH, Serhan CN, Kruger MC.

Am J Hematol. 2008 Jun;83(6):437-45. doi: 10.1002/ajh.21170.

19.

Peroxisome proliferator-activated receptor gamma-mediated up-regulation of syndecan-1 by n-3 fatty acids promotes apoptosis of human breast cancer cells.

Sun H, Berquin IM, Owens RT, O'Flaherty JT, Edwards IJ.

Cancer Res. 2008 Apr 15;68(8):2912-9. doi: 10.1158/0008-5472.CAN-07-2305.

20.

Metabolism of eicosapentaenoic and docosahexaenoic acids by recombinant human cytochromes P450.

Fer M, Dréano Y, Lucas D, Corcos L, Salaün JP, Berthou F, Amet Y.

Arch Biochem Biophys. 2008 Mar 15;471(2):116-25. doi: 10.1016/j.abb.2008.01.002. Epub 2008 Jan 11.

PMID:
18206980

Supplemental Content

Support Center